Fees in Respect of Drugs and Medical Devices Order, SOR/2019-124
Section 38
Fee — licence authorizing packaging/labelling
Cite as Fees in Respect of Drugs and Medical Devices Order, SOR/2019-124, s. 38 · current to July 24, 2025 · regulation last amended May 31, 2025
Statute Watch
Get an alert when a bill in Parliament would change this section, and every time it moves.
The text
For the examination of an application for an establishment licence for each building at which one or more activities are to be conducted, including packaging/labelling drugs — but not fabricating drugs in sterile dosage form, importing drugs, fabricating drugs that are not in sterile dosage form, distributing drugs or wholesaling drugs — the fee is as follows:
(a) in respect of drugs for human use,
(i) in the case of a fee that is payable in a fiscal year set out in any of columns 2 to 5 of Schedule 3, the fee set out in item 6 for that fiscal year, and
(ii) in the case of a fee that is payable in a fiscal year other than one set out in any of columns 2 to 5 of Schedule 3, the amount that is calculated in accordance with subsection 4(2); and
(b) in respect of drugs for veterinary use only,
(i) in the case of a fee that is payable in a fiscal year set out in any of columns 2 to 8 of Schedule 4, the fee set out in item 6 for that fiscal year, and
(ii) in the case of a fee that is payable in a fiscal year other than one set out in any of columns 2 to 8 of Schedule 4, the amount that is calculated in accordance with subsection 4(2).
Read the Fees in Respect of Drugs and Medical Devices Order on the Justice Laws Website ↗
Made under Food and Drugs Act, R.S.C. 1985, c. F-27.
Bills in Parliament that would change this section 0
No bill we hold would amend or repeal this section.